Monetta Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-39,000
Closed -$1.13M 54
2024
Q3
$1.13M Buy
+39,000
New +$1.14M 0.96% 23
2022
Q1
Sell
-27,000
Closed -$1.59M 63
2021
Q4
$1.59M Buy
27,000
+12,000
+80% +$595K 1.23% 18
2021
Q3
$645K Buy
+15,000
New +$665K 0.52% 33
2015
Q3
Sell
-17,918
Closed -$570K 100
2015
Q2
$570K Hold
17,918
0.32% 62
2015
Q1
$591K Buy
+17,918
New +$570K 0.31% 62
2014
Q3
Sell
-89,590
Closed -$2.52M 63
2014
Q2
$2.52M Hold
89,590
1.32% 28
2014
Q1
$2.73M Hold
89,590
1.48% 16
2013
Q4
$2.6M Buy
89,590
+31,620
+55% +$920K 1.51% 19
2013
Q3
$1.58M Hold
57,970
1.22% 34
2013
Q2
$1.54M Buy
+57,970
New +$1.6M 1.38% 31

Other funds holding PFE

Monetta Financial Services's PFE Position: Q4 2024 in Review

Monetta Financial Services sold out of Pfizer (PFE) in Q4 2024, closing a stake of 39,000 shares — an estimated $1.13M sold.

Monetta Financial Services first reported a position in PFE in Q2 2013 and held it in 10 quarters. The position peaked at $2.73M in Q1 2014. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Monetta Financial Services reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Monetta Financial Services sold 39,000 Pfizer shares in Q4 2024, an estimated $1.13M.
  • Monetta Financial Services first reported a position in Pfizer in Q2 2013 and held it in 10 quarters.
  • Monetta Financial Services's Pfizer position peaked at $2.73M in Q1 2014.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Monetta Financial Services's 13F filing for Q4 2024, filed 11 Feb 2025.